To investigate this rigorously we have now undertaken a study of a series of 105 NB tumours to explore ALK copy number gain as well as the frequency and type of ALK mutations that may remain undetected using Sanger-based sequencing methodology. The gene discussed is ALK; the disease is neoplasm.